Beta-adrenergic blockers: Nursing pharmacology

00:00 / 00:00

Notes

BETA-ADRENERGIC BLOCKERS
DRUG NAME
nadolol (Corgard), propranolol (Inderal, InnoPran XL), pindolol (Visken), sotalol (Betapace, Sorine)
atenolol (Tenormin), metoprolol (Lopressor, Toprol XL), carvedilol (Coreg), nebivolol (Bystolic)
CLASS
Nonselective β-blockers
Selective β-blockers
MECHANISM OF ACTION
Block β receptors → prevent catecholamines (norepinephrine and epinephrine) from binding and activating them → decrease cardiac contractility, decrease conduction velocity through AV node, decrease heart rate, cardiac output, and blood pressure
INDICATIONS
  • Hypertension
  • Coronary artery disease; angina pectoris, myocardial infarction
  • Arrhythmias
  • Heart failure
  • Essential tremor
  • Glaucoma
  • Migraine prophylaxis
ROUTE(S) OF ADMINISTRATION
  • PO
  • IV
  • Opth
SIDE EFFECTS
  • Bradycardia
  • Hypotension
  • Fatigue
  • Dizziness
  • Bronchospasm and dyspnea
  • Headache
  • Depression
  • Hallucination
  • Insomnia and nightmares
  • Erectile dysfunction
  • Decreased libido
  • Hyperglycemia
  • Hypertriglyceridemia
  • Hyperkalemia
  • Hypoglycemia unawareness
CONTRAINDICATIONS AND CAUTIONS
  • Bradycardia
  • Hypotension
  • Decompensated heart failure
  • Second or third degree AV block
  • Asthma
  • COPD
  • Diabetes
  • Raynaud phenomenon
  • Severe hepatic or renal disease
NURSING CONSIDERATIONS: BETA-ADRENERGIC BLOCKERS
ASSESSMENT AND MONITORING
  • Baseline assessment
    • Vital signs
    • Orthostatic hypotension
    • Frequency and duration of angina attacks
    • Weight, lung sounds; presence of edema, dyspnea
  • Laboratory test results: renal and hepatic function tests, electrolytes, glucose, lipid panel
  • Diagnostic tests: ECG
  • Monitor
    • Heart rate, blood pressure, ECG
    • Evaluate therapeutic response; e.g., normalized blood pressure, decreased anginal pain, absence of heart failure symptoms
CLIENT EDUCATION
  • Change positions slowly
  • Do not abruptly discontinue medication
  • Self-monitoring of pulse, blood pressure
  • Lifestyle modifications
    • Dietary modifications; e.g., low sodium diet
    • Weight control
    • Regular activity as tolerated
    • Moderate alcohol intake
    • Smoking cessation
  • Clients with diabetes: recognize signs of hypoglycemia; e.g., fatigue, hunger and difficulty concentrating
    • Check blood glucose regularly
  • Report symptoms such as bradycardia, hypotension, hypertension, dyspnea, edema

Memory Anchors and Partner Content

Transcript

Watch video only

Beta-adrenergic blockers, or just beta blockers, are a group of medications that are mainly used to treat cardiovascular conditions like hypertension, coronary artery disease and its manifestations like angina pectoris and myocardial infarction, as well as heart failure and arrhythmias. Beta blockers can also be used to treat essential tremor, glaucoma, and as prophylactic treatment of migraine attacks.

Now, beta blockers work by blocking beta receptors, of which there are three types, known as beta 1, which are mainly found in the heart and kidneys; beta 2, found in the lung bronchioles as well as the arteries of skeletal muscles; and beta 3, found in adipose tissue.

So beta blockers are classified into two main groups; nonselective and selective. Nonselective beta blockers can block both beta 1 and beta 2 receptors, and include nadolol, propranolol, pindolol, and sotalol.

On the other hand, selective beta blockers only block beta 1 receptors, and include atenolol, metoprolol, carvedilol, and nebivolol. So keep in mind that all beta blockers end in -lol, (which is pretty funny) and they can be administered orally, intravenously, or even via the ophthalmic route.

Once administered, beta blockers block beta receptors, thereby preventing the catecholamines norepinephrine and epinephrine from binding and activating them. As a result, beta blockers decrease the sympathetic nervous system response.

Sources

  1. "Beta Blockers" StatPearls [Internet] (2021)
  2. "Focus on Nursing Pharmacology" LWW (2019)
  3. "Pharmacology: A Patient-Centered Nursing Process Approach (8e)" Elsevier Health Sciences (2014)
  4. "Mosby's 2021 Nursing Drug Reference (34e)" Mosby (2020)
  5. "Saunders Comprehensive Review for the NCLEX-RN Examination (8e)" Saunders (2019)
  6. "4.14 Beta-2 Antagonists" Nursing Pharmacology
Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX